Thursday, May 30, 2013

Pharma R&D Spend by Function

Source PhRMA
  1. Phase 3 comprise the largest component of R&D spend by innovator pharma companies 
  2. The second largest component being the preclinical spend which is about 22 percent.
 
 Enter your email address:


Delivered by FeedBurner